Why actives fail in the vehicle, not in the study
Solubility limits, pH windows and interaction effects account for more failed prototypes than ingredient selection ever does.
- Subject
- Formulation chemistry
- Updated
- 2026-02-18
- Reading time
- 6 min
A common pattern in early development: an ingredient with a plausible mechanism and reasonable published support is selected, dosed at the level used in the literature, and placed into a format chosen for commercial reasons. The prototype then separates, discolours, tastes wrong, or loses potency long before a stability programme would have finished.
In most of these cases the ingredient was never the problem. The vehicle was.
The vehicle sets the real constraints
Every delivery format carries an implicit constraint set: how much solid it can hold, what pH range it tolerates, how much water activity it permits, how much heat it sees during processing, and how much sensory burden a user will accept. Those constraints are usually tighter than the dose a study used.
Working backwards from the format is often faster than working forwards from the ingredient. If a capsule cannot physically carry the dose, the interesting question is not which supplier to use — it is whether the dose, the format, or the objective should move.
Three failure modes worth checking on paper
Solubility. An active that requires a solvent system the format cannot accommodate will either fall out of solution or force a compromise elsewhere in the formula.
pH. Many actives have a narrow window of chemical stability. When that window sits outside the range the base needs for preservation or sensory reasons, one of the two has to give.
Interaction. Chelation, oxidation and reaction with common excipients are frequently predictable from an ingredient list before any bench work happens.
What this means for a development plan
Constraint mapping belongs at the start of a project, alongside the objective — not after the first prototype disappoints. Written constraints make revision decisions traceable, and they narrow the number of bench iterations required.
Analytical confirmation of stability and potency is coordinated through qualified third-party laboratories; the purpose of early formulation reasoning is to make sure the sample sent for that work is worth testing.